Product Information
FT PAIN RELIEF 325 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0233 per EA under NDC 70677111901. Its NADAC has been published 152 times since Nov 8, 2023.
Strength
325 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677111901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
6/9/2023
Price Statistics
The NADAC for FT PAIN RELIEF 325 MG TABLET has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0233 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0221 (Nov 20, 2024) |
| 52-week high | $0.0267 |
| 52-week low | $0.0233 |
| Median price | $0.0252 |
| Average price | $0.0249 |
| Largest weekly change | -17.3% (Nov 20, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT PAIN RELIEF 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FT PAIN RELIEF 325 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.0233 per EA (NDC 70677111901), effective Sep 30, 2026.
How has the price of FT PAIN RELIEF 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for FT PAIN RELIEF 325 MG TABLET has declined 4.7%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for FT PAIN RELIEF 325 MG TABLET?
Since Nov 8, 2023, the NADAC for FT PAIN RELIEF 325 MG TABLET has ranged from a low of $0.0221 (Nov 20, 2024) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0252 per EA.
Are there cheaper alternatives to FT PAIN RELIEF 325 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 1% below FT PAIN RELIEF 325 MG TABLET.
Who manufactures FT PAIN RELIEF 325 MG TABLET?
FT PAIN RELIEF 325 MG TABLET (NDC 70677111901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.